Results 91 to 100 of about 48,314 (295)

Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin

open access: yesMolecular Oncology, EarlyView.
The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla   +10 more
wiley   +1 more source

Periodization and its discontents [PDF]

open access: yesJournal of Art Historiography, 2010
This essay originated as an editorial for an issue of Perspective devoted to periodization. It traces the critique and dismantling of this conception in art history, and argues that even most recent literature suggests that the problematic of ...
Thomas DaCosta Kaufmann
doaj  

Peroxidasin enables melanoma immune escape by inhibiting natural killer cell cytotoxicity

open access: yesMolecular Oncology, EarlyView.
Peroxidasin (PXDN) is secreted by melanoma cells and binds the NK cell receptor NKG2D, thereby suppressing NK cell activation and cytotoxicity. PXDN depletion restores NKG2D signaling and enables effective NK cell–mediated melanoma killing. These findings identify PXDN as a previously unrecognized immune evasion factor and a potential target to improve
Hsu‐Min Sung   +17 more
wiley   +1 more source

Structuring of the periodization in antiquity: the Roman military training

open access: yesTanjungpura Journal of Coaching Research
Background and Study Aim. The sportive periodization originated from the military periodization of ancient civilizations and of the Greek Tetrad for the sportive preparation the ancient Greek athletes.
Nelson Kautzner Marques Junior
doaj   +1 more source

Crucial parameters for precise copy number variation detection in formalin‐fixed paraffin‐embedded solid cancer samples

open access: yesMolecular Oncology, EarlyView.
This study shows that copy number variations (CNVs) can be reliably detected in formalin‐fixed paraffin‐embedded (FFPE) solid cancer samples using ultra‐low‐pass whole‐genome sequencing, provided that key (pre)‐analytical parameters are optimized.
Hanne Goris   +10 more
wiley   +1 more source

Solving the Boltzmann equation in N log N

open access: yes, 2006
In [C. Mouhot and L. Pareschi, "Fast algorithms for computing the Boltzmann collision operator," Math. Comp., to appear; C. Mouhot and L. Pareschi, C. R. Math. Acad. Sci. Paris, 339 (2004), pp.
Bird G.   +9 more
core   +4 more sources

ON THE ISSUE OF RE-EVACUATION PROCESS PERIODIZATION

open access: yesВестник Кемеровского государственного университета, 2015
The subject of the research is the re-evacuation process. The purpose of the paper is to set forth and substantiate the author’s view of a very important and problematical component of the re-evacuation process – its periodization.
L. I. Snegireva
doaj  

Combining antibody conjugates with cytotoxic and immune‐stimulating payloads maximizes anti‐cancer activity

open access: yesMolecular Oncology, EarlyView.
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang   +3 more
wiley   +1 more source

A Systematic Review of Meta-Analyses Comparing Periodized and Non-periodized Exercise Programs: Why We Should Go Back to Original Research

open access: yesFrontiers in Physiology, 2019
Periodization schedules training periods according to predicted timings of cumulative adaptations and has been at the foundation of exercise prescription.
José Afonso   +7 more
doaj   +1 more source

TRAIL‐PEG‐Apt‐PLGA nanosystem as an aptamer‐targeted drug delivery system potential for triple‐negative breast cancer therapy using in vivo mouse model

open access: yesMolecular Oncology, EarlyView.
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy